Overcoming tumor-mediated immunosuppression. | Immunotherapy;6(9): 973-88, 2014. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Overcoming tumor-mediated immunosuppression.

Schlößer, Hans Anton; Theurich, Sebastian; Shimabukuro-Vornhagen, Alexander; Holtick, Udo; Stippel, Dirk Ludger; von Bergwelt-Baildon, Michael.

Affiliation

Schlößer HA; Cologne Interventional Immunology, University of Cologne, Cologne, Germany.

Immunotherapy ; 6(9): 973-88, 2014.

Article in En | MEDLINE | ID: mdl-25341119

Subject(s)
Key words

CTLA-4; PD-1; PD-L1; cancer; checkpoint inhibitors; immune escape; immunotherapy; tumor-mediated immunosuppression

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Tolerance / Immunotherapy / Neoplasms Limits: Humans Language: En Journal: Immunotherapy Journal subject: ALERGIA E IMUNOLOGIA / TERAPEUTICA Year: 2014 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Tolerance / Immunotherapy / Neoplasms Limits: Humans Language: En Journal: Immunotherapy Journal subject: ALERGIA E IMUNOLOGIA / TERAPEUTICA Year: 2014 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido